HIV type 1 V3 sequences and the development of dementia during AIDS

AIDS Research and Human Retroviruses

Volumn 12, Issue 6, 1996, Pages 471-476

  Di Stefano, Mariantonietta ^a   Wilt, Susan ^b   Gray, Françoise ^c   Dubois Dalcq, Monique ^b   Chiodi, Francesca ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUT PASTEUR   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ARTICLE; BRAIN TISSUE; CEREBROSPINAL FLUID ANALYSIS; DEMENTIA; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROGLIA; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS REPLICATION;

EID: 0029966409     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.471     Document Type: Article

References (40)

1. Starcich BR, Hahn BH, Shaw GM, et al.: Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 1986;45: 637-648.
2. Willey RL, Rutledge RA, Dias S, et al.: Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc Natl Acad Sci USA 1986;83:5038-5042.
3. Roberts JD, Bebenek K, and Kunkek TA: The accuracy of reverse transcriptase from HIV-1. Science 1988;242:1171-1173.
4. Bebeneck K, Abbotts J, Roberts JD, Wilson SH, and Kunkel TA: Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase. J Biol Chem 1989;264:16948-16956.
5. Chesebro B, Wehrly K, Nishio J, and Perryman S: Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J Virol 1992;66:6547-6554.
6. Westervelt P, Trowbridge DB, Epstein LG, Blumberg BM, Li Y, Hahn BH, Shaw GM, Price EW, and Ratner L: Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol 1992;66(4):2577-2582.
7. Fouchier RAM, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, and Schuitemaker H: Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type -1 -gp120 molecule. J Virol 1992;66:3183-3187.
8. Palker TJ, Clark ME, Langlois AJ, Matthews TJ, Weinhold KJ, Randall RR, Bolognesi DP, and Haynes BF: Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc Natl Acad Sci USA 1988;85:1932-1936.
9. McKeating JA, Gow J, Goudsmit J, Pearl LH, Mulder C, and Weiss RA: Characterization of HIV-1 neutralization escape mutants. AIDS 1989;3:777-784.
10. Epstein LG, Kuiken C, Blumberg B, Hartman S, Sharer LR, Clement M, and Goudsmit J: HIV-1 V3 domain variation in brain and spleen of children with AIDS: Tissue-specific evolution within host-determined quasispecies. Virology 1991;180:583-590.
11. Li Y, Hui H, Burgess CJ, Price RW, Sharp PM, Hahn BH, and Shaw GM: Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: Evidence for limited defectiveness and complementation. J Virol 1992;66:6587-6600.
12. Keys B, Karis J, Fadeel B, Valentin A, Norkrans G, Hagberg L, and Chiodi F: V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stages of disease. Virology 1993;196:475-483.
13. Ball JK, Holmes EC, Whitwell H, and Desselberger U: Genomic variation of human immunodeficiency virus type 1 (HIV-1): Molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy. J Gen Virol 1994;75:867-879.
14. Donaldson YK, Bell JE, Holmés EC, Hughes ES, Brown HK, and Simmonds P: In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol 1994;68:5991-6005.
15. Korber BTM, Kunstman KJ, Patterson BK, Furtado M, McEvilly MM, Levy R, and Wolinsky SM: Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994;68:7467-7481.
16. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, and Chesebro B: Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 1994;68:4643-4649.
17. Kuiken CL, Goudsmit J, Weiller GF, Armstrong JS, Hartman S, Portegies P, Dekker J, and Cornelissen M: Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex. J Gen Virol 1995;76:175-180.
18. Monken CE, Wu B, and Srinivasan A: High resolution analysis of HIV-1 quasispecies in the brain. AIDS 1995;9:345-349.
19. McArthur JC, Hoover DR, Bacellar H, et al.: Dementia in AIDS patients: Incidence and risk factors. Neurology 1993;43:2245-2252.
20. Di Stefano M, Gray F, Leitner T, and Chiodi F: Analysis of env V3 sequences from HIV-1 infected brain indicates restrained virus expression throughout the disease. J Med Virol 1996 (in press).
21. Myers G, Korber B, Wain-Hobson S, Jeang K-T, Henderson LE, and Pavlakis GN: Human Retroviruses and AIDS 1994. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, 1994.
22. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezhkpour GH, Yungblut M, Janotta F, Aksamit A, Martin M, and Fauci AS: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-1093.
23. Wiley CA, Schrier RD, Nelson JA, Lampert PW, and Oldstone MBA: Cellular localization of the human immunodeficiency virus infection within the brains of acquired immunodeficiency syndrome patients. Proc Natl Acad Sci USA 1986;83:7089-7093.
24. Perry VH and Gordon S: Macrophages and microglia in the nervous system. Trends neurosci 1988;11:2273-2277.
25. Hickey WF and Kimura H: Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988;239:290-292.
26. Tornatore C, Chandra R, Berger JR, and Major EO: HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994;44:481-487.
27. Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, Louder M, Golding K, Cvektovich TA, and Blumberg BM: Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994;44: 474-481.
28. Jordan CA, Watkins BA, Kufta C, and Dubois-Dalcq M: Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. J Virol 1991;65:736-742.
29. Watkins BA, Dom HH, Kelly WB, Armstrong RC, Potts B, Michaels F, Kufta CV, and Dubois-Dalcq M: Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 1990;249:549-553.
30. Chiodi F, Albert J, Olausson E, Norkrans G, Hagberg L, Sönnerborg A, Åsjö B, and Fenyö EM: Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection. AIDS Res Hum Retroviruses 1988;4:351-358.
31. Erickson-Miller CL, Abbound CN, and Brennan JK: Purification of GCT cell-derived human colony-stimulating factors. Exp Hematol 1988;16:184-189.
32. Valentin A, Albert J, Fenyö EM, and Åsjö B: Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J Virol 1994;68(10):6684-6689.
33. Budka H: Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS). Acta Neuropathol 1990;79:611-619.
34. Ketzler S, Weis S, Haug H, and Budka H: Loss of neurons in the frontal cortex of AIDS brains. Acta neuropathol 1990;80:92-94.
35. Everall IP, Luthert P, and Lantos PL: Neuronal loss in the frontal cortex in HIV infection. Lancet 1991;337:1119-1121.
36. Seilhean D, Duyckaerts C, Vazeux R, Bolgert F, Brunet P, Katlama C, Gentilini M, and Hauw JJ: HIV-1-associated cognitive/motor complex: Absence of neuronal loss in the cerebral cortex. Neurology 1993;43:1492-1499.
37. Masliah E, Achim CL, Ge N, De Teresa R, Terry RD, and Wiley CA: Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992;32(3):321-329.
38. Elovaara I, Fadeel B, and Chiodi F: HIV-1 infection of the brain: Which pathogenic mechanisms are relevant for tissue damage? Rev Med Virol 1995;5:105-119.
39. Haase AT, Retzel EF, and Staskus KA: Amplification and detection of lentiviral DNA inside cells. Proc Natl Acad Sci USA 1990;87:4971-4975.
40. Di Stefano M, Hinkula J, Fiore JR, Scarlatti G, Major E, and Chiodi F: Infection of human fetal astrocytes by primary HIV-1 isolates. 1996 (submitted).